Application of chromosome microarray analysis and karyotyping in diagnostic assessment of abnormal Down syndrome screening results

被引：0
作者：
Han Kang
Lingxi Wang
Xingyu Li
Chonglan Gao
Yamei Xie
Yu Hu
机构：
[1] University of Electronic Science and Technology of China,Prenatal diagnosis department, Chengdu Women’s and Children’s Central Hospital, School of Medicine
来源：
BMC Pregnancy and Childbirth | / 22卷
关键词：
Chromosome microarray analysis; Down syndrome screening; Karyotyping; Nuchal translucency thickness; Prenatal diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 179 条
[1]  
Merkatz IR(1984)An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities Am J Obstet Gynecol 148 886-894
[2]  
Nitowsky HM(2015)First trimester serum tests for Down's syndrome screening Cochrane Database Syst Rev 11 CD011975-11
[3]  
Macri JN(1999)First-trimester biochemical markers for Down syndrome Prenat Diagn 19 8-887
[4]  
Johnson WE(2015)Diagnostic value of ultrasonographic combining biochemical markers for Down syndrome screening in first trimester: a meta-analysis Prenat Diagn 35 879-47
[5]  
Alldred SK(2014)Screening for Down syndrome Scand J Clin Lab Invest Suppl 244 41-346
[6]  
Takwoingi Y(1998)UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation first trimester screening group Lancet 352 343-869
[7]  
Guo B(1992)Nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy BMJ 304 867-316
[8]  
Pennant M(1992)First-trimester diagnosis of nuchal anomalies: significance and fetal outcome Ultrasound Obstet Gynecol 2 314-2582
[9]  
Deeks JJ(2015)Cell-free DNA analysis for noninvasive examination of trisomy N Engl J Med 373 2581-e69
[10]  
Neilson JP(2020)Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226 Obstet Gynecol 136 e48-305
12345678910